14 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
, comparison and ... #pharmacology #table ... #medications #comparison ... #drugs #treatment ... #pharmacotherapy
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
#antibiotics #medications ... #table #treatment ... #drugs #pharmacotherapy
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
are usually the drugs ... Drug interactions ... #pharmacology #comparison ... #treatment #medications ... #table #pharmacotherapy
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
Summary table of ... anti-inflammatory drugs ... #pharmacology #table ... #comparison #medications ... #treatment
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications ... endocrinology #treatment
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug ... For most indications ... #pharmacology #treatment ... #medications #table ... #pharmacotherapy
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... with ‘treatment ... summarised in Tables ... Personality #Disorder #Medications ... Effectiveness #Table
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Tuberculosis - IDSA ... Guidelines # ... Therapy #regimens #medications ... #Guidelines #Treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... exacerbations Drug ... Dosing: 250 mcg tablet ... recommendations for the treatment ... #Roflumilast #Indications
A toxidrome is a syndrome (set of symptoms) caused by specific medications or toxins.

There are 5
caused by specific medications ... barbituates, “Z-drugs ... antihistamines #Diagnosis ... Toxicology #Toxidromes #Comparison ... #Table #Anticholinergics